Skip to main content
Article thumbnail
Location of Repository

A cost-utility analysis of multivitamin and multimineral supplements in men and women aged 65 years and over

By Mary Mueni Kilonzo, Luke David Vale, Jonathan Alistair Cook, Anne Catherine Milne, Audrey Isabella Stephen, Alison Avenell and MAVIS Trial Group


Background and Aims As people age there is a progressive dysregulation of the immune system that may lead to an increased risk of infections, which may precipitate hospital admission in people with chronic heart or respiratory diseases. Mineral and vitamin supplementation in older people could therefore influence infections in older people. However, the evidence from the available randomised controlled trials is mixed. The aim of the study was to assess the relative efficiency of multivitamin and multimineral supplementation compared with no supplementation. Methods Cost-utility analysis alongside a randomised controlled trial. Participants aged 65 years or over from six general practices in Grampian, Scotland were studied. They were randomised to one tablet daily of either a multivitamin and multimineral supplement or matching placebo. Exclusion criteria were: use of mineral, vitamin or fish oil supplements in the previous three months (one month for water soluble vitamins), vitamin B12 injection in the last three months. Results Nine hundred and ten participants were recruited (454 placebo and 456 supplementation). Use of health service resources and costs were similar between the two groups. The supplementation arm was more costly although this was not statistically significant (£15 per person, 95% CI -3.75 to 34.95). After adjusting for minimisation and baseline EQ-5D scores supplementation was associated with fewer QALYs per person (–0.018, 95% CI -0.04 to 0.002). It was highly unlikely that supplementation would be considered cost-effective. Conclusions The evidence from this study suggests that it is highly unlikely that supplementation could be considered cost-effective.Peer reviewedAuthor versio

Topics: Dietary, Supplement, Vitamins, Aged, Minerals, Cost effectiveness, Nutrition, Quality of life, Randomised controlled trial, Oral nutritional supplementation, Vitamins and Minerals, TX Home economics
Publisher: Elsevier
Year: 2007
DOI identifier: 10.1016/j.clnu.2006.11.002
OAI identifier:

Suggested articles


  1. (1999). Immune response during disease and recovery in the elderly.
  2. Impact of respiratory virus infections on persons with chronic underlying conditions.
  3. (1997). Synergism of nutrition, infection, and immunity: an overview.
  4. Role of multivitamins and mineral supplements in preventing infections in elderly people: systematic review and meta-analysis of randomized controlled trials.
  5. (1993). Does multivitamin supplementation prevent infections in healthy elderly subjects? A controlled trial.
  6. Effect of daily vitamin E and multivitaminmineral supplementation on acute respiratory infections in elderly persons. A randomised controlled trial.
  7. (2003). Effect of a multivitamin and mineral supplement on infection and quality of life. A randomised, double-blind, placebo-controlled trial. Ann Intern Med
  8. (2005). of the MAVIS trial. Effect of multivitamin and multimineral supplements on morbidity from infections in older people (MAVIS trial): pragmatic, randomized, double-blind, placebo controlled trial. BMJ
  9. (2003). Scottish Health Service Costs
  10. (2002). Unit Costs of Health and Social Care. Personal Social Services Research Unit.
  11. (2004). Association, Royal Pharmaceutical Society of Great Britain.
  12. (2004). to the Statement of Dental Remuneration.
  13. (1999). UK Population norms for EQ-5D. Centre for Health Economics Discussion paper 172.
  14. (2004). for Health and Clinical Excellence (NICE). Guide to the methods of technology appraisal.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.